Full-Spectrum Evidence
Observational. Interventional. Everything in between.
Observational. Interventional. Everything in between.
Powered by an engaged network of health systems and investigators
Delivered at the pace of life sciences innovation
Full-Spectrum Evidence
Observational. Interventional. Everything in between.
More molecules are entering trials, more approvals have confirmatory evidence needs, and the system can't keep up.
The Question
The Decision
The Evidence Gap
The pieces already exist, but need a better way of working together.
Academic and community sites, connecting records into one longitudinal view.
They join the research and tell us what the chart can't.
Ready to run prospective studies and trials without starting from scratch.
Beginning in hepatology, dermatology, and gastroenterology.
Our team partners with you to generate the right combination of data and studies, for a single research question or across an entire research program.
Our clinicians, epidemiologists, and scientists design and conduct the study with you using our longitudinal, analysis-ready data.
Seamlessly activate patients within the network to collect new information not captured in routine care.
Interventional trials run end to end, with investigators who already treat your patients.
The right treatment, for the right patient, at the right time.

Evidence that carries forward from early development through approval and real-world use.
Clinical development
Natural history, feasibility, protocol design and external control arms
Regulatory
Post-authorization safety studies and longitudinal evidence for submissions
HEOR & market access
Comparative effectiveness and market access evidence
Medical affairs
Real-world treatment patterns and publication strategy

Research partnerships across academic and community settings.
Act on curated data from your own system
Clinician-defined variables, linked to your own patients, under your governance
Learn at network scale
Study your own cohort alone or alongside the network, and publish from either
Lead prospective and interventional studies
Sponsored studies that fund your research program
Now we're writing the next chapter. Join us.
130+
publications and congress presentations across hepatology, dermatology and gastroenterology
30+
life sciences organizations have trusted us to generate evidence

Amy Abernethy, MD, PhD
Co-CEO
Cofounder of Highlander Health and former principal deputy commissioner of the FDA. A hematologist/oncologist and palliative medicine physician with 500+ publications, she has led change at Flatiron Health, Duke University and Verily.

Brad Hirsch, MD
Co-CEO
Cofounder of Highlander Health and an oncologist, trialist, entrepreneur and product leader. He founded SignalPath, a clinical research technology company acquired by Verily, where he went on to lead product.

Michael W. Fried, MD, FAASLD
Co-Founder & Chief Clinical Officer
Professor of Medicine at UNC Chapel Hill and past president of the American Association for the Study of Liver Diseases, with 30 years in clinical research and 200+ publications in liver disease.

By submitting this form, you consent to your information used by Pedestal Health for the purpose of contacting you to better understand your potential interest in Pedestal Health and/or its services. For more information, see our privacy policy.